Back to Companies who have applied for FDA Drug Approval

FDA Drug Approval Applications Sponsored by VIIV HLTHCARE

Application NumberDrugs/ProductsApplication TypeMost Recent Label Available FlagCurrent Patent FlagAction TypeChemical TypeTher PotentialOrphan Code
019655 New Drug Application Approval New molecular entity (NME) (P*) Priority review drug* (V) Orphan drug
019910 New Drug Application Approval New formulation (P*) Priority review drug*
019951 New Drug Application Approval New formulation (P*) Priority review drug*
020518 New Drug Application Approval New formulation (S) Standard review drug
020564 New Drug Application Approval New molecular entity (NME) (P*) Priority review drug*
020596 New Drug Application Approval New formulation (P*) Priority review drug*
020705 New Drug Application Approval New molecular entity (NME) (P) Priority review drug
020857 New Drug Application Approval New combination (P) Priority review drug
020977 New Drug Application Approval New molecular entity (NME) (P) Priority review drug
020978 New Drug Application Approval New formulation (P) Priority review drug
021205 New Drug Application Approval New formulation (P) Priority review drug
021548 New Drug Application Approval New ester, new salt, or other noncovalent derivative (S) Standard review drug
021652 New Drug Application Approval New formulation (S) Standard review drug
022116 New Drug Application Approval New formulation (P) Priority review drug
022128 New Drug Application Approval New molecular entity (NME) (P) Priority review drug
204790 New Drug Application Approval New molecular entity (NME) (P) Priority review drug
205551 New Drug Application Approval New combination (S) Standard review drug

Back to Companies who have applied for FDA Drug Approval